Form 4 for NVCR NovoCure Ltd
Accepted 2022-09-19 00:00:00 ET · period of report 2022-09-15 · accession 0001645113-22-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-19 | 2022-09-15 | NVCR | Leonard Frank X | Chief Development Off | S - Sale+OE | $88.52 | -12.3K | 70.6K | -15% | -$1.09M |
| D | 2022-09-19 | 2022-09-15 | NVCR | Leonard Frank X | Chief Development Off | M - OptEx | $7.15 | +5,517 | 82.9K | +7% | +$39.4K |
| D | 2022-09-19 | 2022-09-15 | NVCR | Leonard Frank X | Chief Development Off | M - OptEx | $0.00 | -5,517 | 5,517 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-09-15 | S | D | 6,754 | $87.31 | 76,159 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard. |
| 2 | Common | Ordinary Shares | 2022-09-15 | M | A | 5,517 | $7.15 | 82,913 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard. |
| 3 | Common | Ordinary Shares | 2022-09-15 | S | D | 5,517 | $90.00 | 70,642 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard. |
| 4 | Derivative | Options to Buy Ordinary Shares | 2022-09-15 | M | D | 5,517 | $0.00 | 5,517 | D | $7.15 · — to 2027-02-21 | 5,517 Ordinary Shares | (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard. (F2) Fully vested as of the date hereof. |